EUVIMEDEUVIMED entdecken
Crossref

A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma

Yao Liu, Zhichao He, Heng Liang, Minzhen Han, Jinxingyi Wang, Qian Liu, Yanping Guan

Analytical Biochemistry · 2023

DOI: 10.1016/j.ab.2023.115230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2023. Verfasst von Yao Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-Sen University, Zhuhai, 519000, China; Institute of Clinical…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Science and Technology Program of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapidly developing UHPLC-MS/MS bioassays with high throughput and quality are challenging yet desired in routine clinics. METHODS & RESULTS: A high-throughput UHPLC-MS/MS bioassay has been built for simultaneously quantifying gefitinib, ruxolitinib, dasatinib, imatinib, ibrutinib, methotrexate, cyclophosphamide and paclitaxel. After the protein precipitation with methanol, samples were separated on an Acquity BEH C18 column following a gradient elution system with methanol and 2 mM ammonium acetate in water at 40 °C with a run time of 3 min (flow rate 0.4 mL/min). Mass quantification in the positive ion SRM mode was then performed with electrospray ionization. The method of specificity, linearity, accuracy, precision, matrix effects, recovery, stability, dilution integrity and carryover were all validated as per the guideline of the China Food and Drug Administration whose values met the admissible limits. Application of the bioassay to therapeutic drug monitoring revealed important variability in the studied anti-tumour drugs. CONCLUSION: This validated approach was shown to be reliable and effective in clinical management, being a valuable support in therapeutic drug monitoring and subsequent individualized dosing optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAntineoplastic AgentsChromatography, High Pressure LiquidMethanolCyclophosphamideReproducibility of Results

Stichwörter der Autor:innen

Anti-tumorHigh-throughputTherapeutic drug monitoringUHPLC-MS/MS

Substanzen

MethanolAntineoplastic AgentsCyclophosphamide

Autor:innen und Institutionen

  • Department of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-Sen University, Zhuhai, 519000, China; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen Universi…
  • Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • The Second Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou, 556000, China.
  • The Second Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou, 556000, China; Guangdong RangerBio Technologies Co., Ltd., Dongguan 523000, China. Electronic address: liuq369@mail.sysu.edu.cn.
  • Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China. Electronic address: guanyp6@mail.sysu.edu.cn.

Förderung

  • Science and Technology Program of Guizhou Province

Zitieren

APA

Liu, Y., He, Z., Liang, H., Han, M., Wang, J., Liu, Q., & Guan, Y. (2023). A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2023.115230

Vancouver

Liu Y, He Z, Liang H, Han M, Wang J, Liu Q, et al. A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma. Analytical Biochemistry. 2023. doi:10.1016/j.ab.2023.115230

BibTeX
@article{Liu2023,
  author = {Liu, Yao and He, Zhichao and Liang, Heng and Han, Minzhen and Wang, Jinxingyi and Liu, Qian and Guan, Yanping},
  title = {A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma},
  journal = {Analytical Biochemistry},
  year = {2023},
  doi = {10.1016/j.ab.2023.115230}
}
Kostenlos starten →